Hospital Acquired Disease Testing Market Expected to Reach USD 7.5 Billion Globally in 2019: Transparency Market Research

January 20, 2014

ALBANY, New York., January 20, 2014 /PRNewswire/ –

According to a new market report published by Transparency Market Research “Hospital
Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA
Infection, and Others) – Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 – 2019″, the global hospital acquired disease testing market was valued at
USD 2.2 billionin 2012 and is expected to grow at a CAGR of 19.3% from 2013 to 2019, to
reach an estimated value of USD 7.5 billion in 2019.

Browse the full report with TOC at


Nosocomial infections/hospital acquired diseases/hospital associated infections
(HAI)form one of the critical areas of focus in the healthcare industry. Factors such as
increasing prevalence of such conditions in neonatal and geriatric population, initiatives
taken up by governments to manage nosocomial infections, increasing number of diseases
that increases risk of hospital associated infections, and growing concerns about control
and prevention of nosocomial infections worldwide will have a positiveimpact on the
current hospital acquired disease testing industry.

The global hospital acquired disease testing market is segmented on the basis of type
of infection and geography. Based on the different typesof infection,this market is
classified into pneumonia, urinary tract infection, blood stream infection, surgical site
associated infection, MRSA infection testing and others. The hospital acquired urinary
tract infection diagnostics segment occupies the largest market share in this category as
prevalence and morbidity rate of this condition, and the demand for diagnostic solutions
for the same is the highest as compared to other hospital associated infections. It is
expected that the global market for hospital associated urinary tract infection testing
will reach USD 2,188.8 million in 2019 with the market growing at CAGR of 18.1%from 2013
to 2019. Furthermore, other testing solutions for conditions such as surgical site
infections and pneumonia (hospital associated and ventilator associated infections) will
also experience high demand in lesser developed regions of Asia-Pacific, Latin America and
other developing countries where the prevalence of such conditions is higher. It is
expected that the market for surgical site infections will grow at a CAGR of 20.1%during
the given period of forecast.

Geographically, United States and Canada together are the leaders inthe global
hospital acquired disease testing market with a combined market share (of the North
American region) of 41.3% in 2012. Some of the major growth drivers for the North American
nosocomial infection testing market include existence of highly developed healthcare
infrastructure, high rate of implementation of healthcare guidelines given by regulatory
and guiding institutions such as Centers for Disease Control and Prevention (U.S.), and
increasing awareness about these diseases and their prevention. The European Union
considers infectious diseases as an increasing threat to the general public health; the
public health system in this region is increasingly engaging itself in conducting dialogue
between healthcare providers and medical practitioners for developing better, faster and
cost effective methods for nosocomial infection management and prevention. Asian countries
including China, Philippines and India are the most potential markets for such diagnostic
and testing solutions owing to existence of factors such as higher population, poor
hospital infrastructure, lack of adherence to sanitation procedures and thereforehigher
disease prevalence growth rates. UAE and African countries are some of the lucrative
markets in the Rest of the World (RoW).

Molecular diagnostics solutions play a vital role in this market as they offer
precise, faster and cost effective diagnosis for various nosocomial infections.
Considering the market competition, the global hospital acquired infection testing market
is highly fragmented and is characterized by the existence of several large and mid-sized
diagnostic solution providers. Some of the key market players contributing to this
industry include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La
Roche,Cepheid, Inc.,Life Technologies Corporation, Meridian Biosciences, Cantel Medical
Corporation, Nordion, Inc. and others.

Related & Recently Published Reports by Transparency Market Research

        - Unsaturated Polyester Resin Market:


        - Caprolactam (Nylon 6 Fiber and Nylon 6 Resin) Market:


        - Latin America Adhesives and Sealants Market:


        - Power Rental Market:


        - Operating Room Equipment Market:


The global hospital acquired disease testing market is segmented as follows:

Hospital Acquired Disease TestingMarket, by Infection Type

        - Pneumonia infection
        - Urinary tract infection
        - Blood stream associated infection
        - Surgical site infection
        - MRSA infection
        - Others

Hospital Acquired Disease TestingMarket, by Geography

        - North America
        - Europe
        - Asia-Pacific
        - Rest of the World

Browse all Medical Devices Market Research Reports @


About Us

Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze

Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business


        Sheela AK
        90 Sate Street, Suite 700
        Albany, NY 12207
        Tel: +1-518-618-1030
        USA - Canada Toll Free: 866-552-3453
        Email: sales@transparencymarketresearch.com
        Web: http://www.transparencymarketresearch.com
        Blog: http://www.tmrblog.com
        Blog: http://transparencymarketresearch.areavoices.com

SOURCE http://www.transparencymarketresearch.com/

Source: PR Newswire

comments powered by Disqus